"AMRI provides scientific services, products and technologies that improve quality of life while delivering excellence, value and maximum return."

Founded in 1991 as Albany Molecular Research, Inc., AMRI (NASDAQ: AMRI) provides scientific services, products and technologies focused on improving the quality of life.  The company has steadily evolved, with global facilities now in the United States, Europe and Asia.  Its 1,200+ employees have the experience and commitment necessary to provide customers with a wide range of services, technologies and cost models.

AMRI performs services including drug discovery, pharmaceutical development, and manufacturing of active ingredients and pharmaceutical intermediates for many of the world's leading healthcare companies.

A separate, stand alone R&D division of the company is also developing technology that it intends to partner and outlicense, an area often viewed as a higher value added service to the many companies with which AMRI is working.